Molecular Effect of EGCG/DAC Chemotherapy on Wnt Signaling in Triple Negative Breast Cancer.Hafez, Salwa.
Abstract: Triple negative breast cancer (TNBC) cannot be treated with the conventional targeted breast cancer therapies. Thus, investigating potential signaling pathways and specific targets is highly desired. One of those pathways is Wnt/-catenin signaling pathway, which is known to have elevated activity in TNBC, and that may contribute to the invasiveness of this type of cancer. HBP1 is a suppr... read more
- Sackler School of Graduate Biomedical Sciences. Department of Pharmacology and Experimental Therapeutics.
- Permanent URL
|To Cite:||DCA Citation Guide|